EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target

Jindong Xie, Anli Yang, Qianwen Liu, Xinpei Deng, Guangzhao Lv, Xueqi Ou, Shaoquan Zheng, Min-Yi Situ, Yang Yu, Jie-Ying Liang, Yutian Zou iD, Hailin Tang iD und 4 weitere

Cell Proliferation · 2024-11 · 57 (11)

DOI: 10.1111/cpr.13697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 29.06.2024. Verfasst von Jindong Xie und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Breast Neoplasms, Brain Neoplasms, Single-Cell Analysis, Sequence Analysis, RNA. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research-oriented Hospital Program of Guangzhou, Basic and Applied Research Fund of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Distant metastasis remains the primary cause of morbidity in patients with breast cancer. Hence, the development of more efficacious strategies and the exploration of potential targets for patients with metastatic breast cancer are urgently needed. The data of six patients with breast cancer brain metastases (BCBrM) from two centres were collected, and a comprehensive landscape of the entire tumour ecosystem was generated through the utilisation of single‐cell RNA sequencing. We utilised the Monocle2 and CellChat algorithms to investigate the interrelationships among each subcluster. In addition, multiple signatures were collected to evaluate key components of the subclusters through multi‐omics methodologies. Finally, we elucidated common expression programs of malignant cells, and experiments were conducted in vitro and in vivo to determine the functions of interleukin enhancer‐binding factor 2 ( ILF2 ), which is a key gene in the metastasis module, in BCBrM progression. We found that subclusters in each major cell type exhibited diverse characteristics. Besides, our study indicated that ILF2 was specifically associated with BCBrM, and experimental validations further demonstrated that ILF2 deficiency hindered BCBrM progression. Our study offers novel perspectives on the heterogeneity of BCBrM and suggests that ILF2 could serve as a promising biomarker or therapeutic target for BCBrM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBrain NeoplasmsSingle-Cell AnalysisSequence Analysis, RNAHumansFemaleNuclear Factor 45 ProteinCell Line, TumorAnimalsMiceGene Expression Regulation, NeoplasticMice, Nude

Substanzen

ILF2 protein, humanNuclear Factor 45 Protein

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Breast, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, Guangdong, China.
  • Department of Breast Cancer, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.

ORCID-Profile: Yutian Zou, Hailin Tang

Förderung

  • Research-oriented Hospital Program of Guangzhou
  • Basic and Applied Research Fund of Guangdong Province
  • National Natural Science Foundation of China
  • Guangzhou Science and Technology Plan Project
  • the Postdoctoral Fellowship Program of CPSF

Zitieren

APA

Xie, J., Yang, A., Liu, Q., Deng, X., Lv, G., Ou, X., Zheng, S., Situ, M. Y., Yu, Y., Liang, J. Y., Zou, Y., Tang, H., Zhao, Z., Lin, F., Liu, W., & Xiao, W. (2024). Single‐cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target. Cell Proliferation, 57(11). https://doi.org/10.1111/cpr.13697

Vancouver

Xie J, Yang A, Liu Q, Deng X, Lv G, Ou X, et al. Single‐cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target. Cell Proliferation. 2024;57(11). doi:10.1111/cpr.13697

BibTeX
@article{Xie2024,
  author = {Xie, Jindong and Yang, Anli and Liu, Qianwen and Deng, Xinpei and Lv, Guangzhao and Ou, Xueqi and Zheng, Shaoquan and Situ, Min-Yi and Yu, Yang and Liang, Jie-Ying and Zou, Yutian and Tang, Hailin and Zhao, Zijin and Lin, Fuhua and Liu, Wei and Xiao, Weikai},
  title = {Single‐cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target},
  journal = {Cell Proliferation},
  year = {2024},
  volume = {57},
  number = {11},
  doi = {10.1111/cpr.13697}
}
Kostenlos starten →